TY - JOUR
T1 - Wernicke encephalopathy in pediatric neuro-oncology
T2 - Presentation of 2 cases and review of literature
AU - Cefalo, Maria Giuseppina
AU - De Ioris, Maria Antonietta
AU - Cacchione, Antonella
AU - Longo, Daniela
AU - Staccioli, Susanna
AU - Arcioni, Francesco
AU - Bernardi, Bruno
AU - Mastronuzzi, Angela
PY - 2014
Y1 - 2014
N2 - Wernicke encephalopathy represents a well-known entity characterized by a set of cognitive and neurologic alterations. Wernicke encephalopathy is rare and under-recognized in childhood and may be fatal. Few cases have been documented in pediatric oncology. We report on 2 Wernicke encephalopathy cases that occurred in children having a brain tumor. The diagnosis of Wernicke encephalopathy was suggested by clinical manifestations associated with the typical radiologic findings and a laboratory evidence of thiamine deficiency. No large series have been published to support the evidence that pediatric malignancies represent a demonstrated factor of increased risk to develop a Wernicke encephalopathy. Moreover, the diagnosis may be even more difficult in brain tumors, considering the overlapping symptoms and the risk of encephalopathy related to both the disease and the treatment. Wernicke encephalopathy should be considered in all childrenwith cancer presenting a neurologic deterioration, mainly in brain tumors. An early diagnosis is imperative for a prompt therapy that might prevent or minimize the irreversible brain damage related to this condition.
AB - Wernicke encephalopathy represents a well-known entity characterized by a set of cognitive and neurologic alterations. Wernicke encephalopathy is rare and under-recognized in childhood and may be fatal. Few cases have been documented in pediatric oncology. We report on 2 Wernicke encephalopathy cases that occurred in children having a brain tumor. The diagnosis of Wernicke encephalopathy was suggested by clinical manifestations associated with the typical radiologic findings and a laboratory evidence of thiamine deficiency. No large series have been published to support the evidence that pediatric malignancies represent a demonstrated factor of increased risk to develop a Wernicke encephalopathy. Moreover, the diagnosis may be even more difficult in brain tumors, considering the overlapping symptoms and the risk of encephalopathy related to both the disease and the treatment. Wernicke encephalopathy should be considered in all childrenwith cancer presenting a neurologic deterioration, mainly in brain tumors. An early diagnosis is imperative for a prompt therapy that might prevent or minimize the irreversible brain damage related to this condition.
KW - Brain cancer
KW - Childhood
KW - Wernicke encephalopathy
UR - http://www.scopus.com/inward/record.url?scp=84927767132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927767132&partnerID=8YFLogxK
U2 - 10.1177/0883073813510355
DO - 10.1177/0883073813510355
M3 - Article
C2 - 24293308
AN - SCOPUS:84927767132
SN - 0883-0738
VL - 29
SP - NP181-NP185
JO - Journal of Child Neurology
JF - Journal of Child Neurology
IS - 12
ER -